CCBG
Capital City Bank Group, Inc.
CCBG's outlook is improving, though it still trails on the overall score.
MS
Morgan Stanley
MS has the edge over CCBG overall, supported by stronger fundamentals and stronger modeled upside.
CCBG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
CCBG's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CCBG.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
CCBG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $39.02 | -24% |
| Fair | 12x | $43.99 | -14% |
| Forward | 13x | $51.09 | — |
| Expensive | 14x | $52.19 | +2.2% |
| Current | 14x | $51.09 | — |
Historical ranges are pointers, not guarantees.
CCBG has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
CCBG Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect CCBG's earnings to grow and its profitability to improve, with its revenue holding steady.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over CCBG on the outlook, with more favorable valuation and revenue expectations.
CCBG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.80 | +3.8% |
| Q3 2026 | $3.66 | +2.2% |
| Q2 2026 | $3.60 | +5.3% |
| Q1 2026 | $3.53 | +4.7% |
| Q4 2025 | $3.60 | +15% |
| Q3 2025 | $3.58 | +18% |
| Q2 2025 | $3.42 | +14% |
| Q1 2025 | $3.37 | +12% |
| Q4 2024 | $3.12 | +1.6% |
CCBG's earnings per share have climbed steadily: $3.66 over the past year, up 2.2% from the year before, and higher year over year for 16 quarters in a row.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over CCBG on earnings, with stronger typical year-over-year growth.
CCBG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.4M | -2.3% |
| Q2 2026 | $64.8M | +2.5% |
| Q1 2026 | $62.8M | +2.1% |
| Q4 2025 | $63.5M | +6% |
| Q3 2025 | $65.9M | +10% |
| Q2 2025 | $63.2M | +7.3% |
| Q1 2025 | $61.5M | +8.9% |
| Q4 2024 | $59.9M | +6.3% |
CCBG's revenue has held roughly level: $64M last quarter, down 2.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | +2.4 points |
| Q2 2026 | 33% | +1.1 points |
| Q1 2026 | 33% | -2.8 points |
| Q4 2025 | 29% | +0.3 points |
| Q3 2025 | 32% | +5.9 points |
| Q2 2025 | 32% | +2.4 points |
| Q1 2025 | 36% | +8.6 points |
| Q4 2024 | 29% | +3.6 points |
CCBG has the edge over MS on profitability, with a higher operating margin.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over CCBG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
CCBG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $29.2M | +47% |
| Q2 2026 | $7.5M | -76% |
| Q1 2026 | $14.7M | -25% |
| Q4 2025 | $9.9M | +11% |
| Q3 2025 | $19.8M | +89% |
| Q2 2025 | $30.8M | +34% |
| Q1 2025 | $19.5M | +57% |
| Q4 2024 | $9M | +199% |
CCBG has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
CCBG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26K shares |
| 1 year | +0.4% | +64K shares |
| 3 years | +1% | +167K shares |
| 5 years | +1.9% | +313K shares |
CCBG has 17M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $2.6M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
CCBG spent $3M buying back its own shares over the past year, after none the year before.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over CCBG on shareholder dilution, with a more favorable share count trend.
CCBG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.0x | Very low |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.0x | Very low |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
CCBG has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
CCBG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.4 | Neutral |
| Stochastic | 53.7 | Neutral |
CCBG's weekly RSI is 59 (neutral) and its Stochastic is 54 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
CCBG PE vs Financial Services Sector
| Metric | CCBG | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 7.2% above |
| PE % | 80 | 63 | 17 pts above |
CCBG has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
CCBG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $49.9 | 2.3% above |
| 20 week MA | $50.6 | 0.9% above |
| 50 week MA | $47.0 | 8.8% above |
| 100 week MA | $42.8 | 20% above |
| 200 week MA | $36.8 | 39% above |
CCBG has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
CCBG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.4 | $24.8 | -18% |
| 2021 | $24.8 | $26.6 | +7.2% |
| 2022 | $26.6 | $33.2 | +25% |
| 2023 | $33.2 | $29.4 | -11% |
| 2024 | $29.4 | $36.6 | +24% |
| 2025 | $36.6 | $42.6 | +16% |
| 2026 YTD | $42.6 | $51.1 | +20% |
CCBG has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.